You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Phase II study to Assess the Efficacy of 28 Day Oral Administration of AZD1236 in Adult Patients with Cystic Fibrosis
- Disease
- chronic obstructive pulmonary disease
- Drug Name
- AZD1236
- Generic Name
- AZD1236
- Sponsor
- AstraZeneca
- Drug Status
- Discontinued
- Phase
- II
- Start Date
- Jan 18, 1971
- Study Name
- D4260C00008
- Study Id
- D4260C00008
- ClinicalTrials.gov ID
- NCT00812045
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
